FDA interrompe o uso de anticorpos monoclonais que não funcionam contra a Ômicron.
31 Jan, 2022 | 08:56hFDA halts use of antibody drugs that don’t work vs. omicron – Associated Press
Conteúdo relacionado: Lab study shows new antiviral pills maintain efficacy against Omicron, but antibody drugs are substantially less effective.